Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
142047-97-0
17640-26-5
17639-73-5
110-99-6
120289-22-7
817-95-8
2183440-34-6 | Methyltetrazine-PEG8-NHS ester | AA019EET | MFCD31580145
1367552-84-8 | (2S)-4-hydroxy-4-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid | AA019EIB | MFCD29917033
147900-32-1 | Ethyl 2-amino-2-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-yl)acetate hcl | AA019ELG | MFCD30471993
1273566-11-2 | Racemic-(3r,3as,6as)-5-(tert-butoxycarbonyl)hexahydro-2h-furo[2,3-c]pyrrole-3-carboxylic acid | AA019EOQ | MFCD18793343
80662-80-2 | 3-[Benzyl-(2-hydroxy-propyl)-amino]-propan-1-ol | AA019ERK | MFCD30185874
1956377-30-2 | (3-Fluorocyclopentyl)methanamine hydrochloride | AA019EV2 | MFCD27997394
98546-57-7 | 5-Bromo-3-isopropylpyrazin-2-ol | AA019EY9 | MFCD31555295
57852-57-0 | Idarubicin Hydrochloride | AA019FQD | MFCD00897212
1357503-31-1 | Imidazole-1-sulfonylazidetetrafluoroborate-I6998 | AA019G56 | MFCD22421714
169945-27-1 | 4-[(2-methoxyphenyl)sulfamoyl]benzoic acid | AA019GID | MFCD02714420
